141 related articles for article (PubMed ID: 25282706)
1. Validation of a multigenic model to predict seizure control in newly treated epilepsy.
Shazadi K; Petrovski S; Roten A; Miller H; Huggins RM; Brodie MJ; Pirmohamed M; Johnson MR; Marson AG; O'Brien TJ; Sills GJ
Epilepsy Res; 2014 Dec; 108(10):1797-805. PubMed ID: 25282706
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
6. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
[TBL] [Abstract][Full Text] [Related]
7. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
8. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Battino D; Tomson T; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Epilepsia; 2013 Sep; 54(9):1621-7. PubMed ID: 23848605
[TBL] [Abstract][Full Text] [Related]
9. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine versus carbamazepine monotherapy for epilepsy.
Gamble CL; Williamson PR; Marson AG
Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
12. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
[TBL] [Abstract][Full Text] [Related]
13. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
14. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
15. Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases.
Petrovski S; Szoeke CE; Sheffield LJ; D'souza W; Huggins RM; O'brien TJ
Pharmacogenet Genomics; 2009 Feb; 19(2):147-52. PubMed ID: 19077679
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological outcomes in newly diagnosed epilepsy.
Mohanraj R; Brodie MJ
Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
Brodie MJ; Richens A; Yuen AW
Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545
[TBL] [Abstract][Full Text] [Related]
18. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
[TBL] [Abstract][Full Text] [Related]
19. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Brigo F; Igwe SC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
[TBL] [Abstract][Full Text] [Related]
20. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
Steinhoff BJ; Maren Staack A; Wisniewski I
Epileptic Disord; 2012 Dec; 14(4):379-87. PubMed ID: 23274162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
